Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Prepaid Assets (2016 - 2026)

Usana Health Sciences has reported Prepaid Assets over the past 16 years, most recently at $25.5 million for Q2 2026.

  • Quarterly Prepaid Assets fell 9.77% to $25.5 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $25.5 million through Apr 2026, down 9.77% year-over-year, with the annual reading at $23.1 million for FY2026, 381.11% up from the prior year.
  • Prepaid Assets was $25.5 million for Q2 2026 at Usana Health Sciences, up from $23.1 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $35.9 million in Q2 2023 and troughed at $4.8 million in Q4 2024.
  • The 5-year median for Prepaid Assets is $26.4 million (2022), against an average of $24.6 million.
  • Year-over-year, Prepaid Assets crashed 81.42% in 2024 and then soared 381.11% in 2026.
  • A 5-year view of Prepaid Assets shows it stood at $7.1 million in 2022, then surged by 263.32% to $25.9 million in 2023, then crashed by 81.42% to $4.8 million in 2024, then skyrocketed by 481.01% to $27.9 million in 2025, then dropped by 8.83% to $25.5 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Prepaid Assets are $25.5 million (Q2 2026), $23.1 million (Q1 2026), and $27.9 million (Q3 2025).